DaVita Accelerates Commitment to Community Health with Nationwide Tour
Rhea-AI Summary
DaVita (NYSE: DVA), a leading kidney care provider, has announced its 2024 nationwide community health tour starting September 24. The DaVita Health Tour offers free health screenings and chronic disease education across the country. This year's tour features an enhanced experience in collaboration with the American Diabetes Association (ADA), focusing on diabetes and chronic kidney disease (CKD) education, especially for underserved populations.
The tour will provide free screenings in California, Florida, Georgia, Pennsylvania, and Texas, regions with higher kidney disease prevalence. Screenings include glucose tests, blood pressure readings, BMI calculations, and optional blood draws for detailed kidney function assessment. This initiative aims to identify potential risk factors for CKD, diabetes, and hypertension early, allowing for timely intervention.
Positive
- Expansion of free health screening program to multiple states
- Collaboration with American Diabetes Association to enhance diabetes and CKD education
- Proactive approach to chronic disease prevention and early detection
- Targeting regions with higher prevalence of kidney disease for maximum impact
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DVA declined 0.59%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Kidney care leader provides free health screenings and resources to create awareness around kidney disease and open discussion around health care access
The 2024 tour will feature an enhanced experience in collaboration with the American Diabetes Association (ADA). DaVita and the ADA have established a multi-year collaboration focused on strengthening diabetes and chronic kidney disease (CKD) education, awareness and support, especially for underserved populations. The organizations will join forces to offer mobile pop-up screenings in select markets, providing more opportunities to reach communities in greater need.
"Health care providers are often playing defense when it comes to caring for some of the most vulnerable members of our communities. We're actively working to put them on offense through proactive patient engagement, education and resources that help address chronic disease preventatively," said Dr. Jeff Giullian, chief medical officer at DaVita. "The DaVita Health Tour is one of many ways we're supporting prevention and access to care with a community-driven focus—at both the national and local levels."
Free screenings will be available in communities across
"Connecting with people at stops throughout the tour has thrown into sharp focus the very real need to create and help ensure access to health care as a human right," Dr. Giullian said. "This tour is illustrative of our broader commitment to engaging with people who don't have access to care or don't know where to find resources."
The free health screenings available at each tour stop are designed to help individuals identify potential risk factors for CKD, diabetes and hypertension so they can work with their care provider to plan appropriate intervention as needed. Each screening includes:
- A glucose test via fingerstick to understand diabetes risk
- A blood pressure reading for hypertension awareness
- Measurements to calculate body mass index (BMI) and assess obesity risk
- An optional blood draw to offer more detailed measurement of kidney function
- A personal and confidential patient results review
To see where the DaVita Health Tour is heading and sign up for a free health screening, visit: DaVita.com/HealthTour.
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in
Media Contact:
DaVita Newsroom
newsroom@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-accelerates-commitment-to-community-health-with-nationwide-tour-302250103.html
SOURCE DaVita
